PHR:NYE-Phreesia Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 24.39

Change

+0.69 (+2.91)%

Market Cap

USD 1.30B

Volume

0.40M

Analyst Target

USD 30.11
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
VEEV Veeva Systems Inc Class A

+1.82 (+0.91%)

USD 32.00B
SOLV Solventum Corp.

+2.60 (+4.21%)

USD 11.73B
DOCS Doximity Inc

+0.23 (+0.97%)

USD 4.83B
EVH Evolent Health Inc

-0.67 (-2.37%)

USD 3.36B
TDOC Teladoc Inc

-0.32 (-2.40%)

USD 2.20B
AGTI Agiliti Inc

+0.01 (+0.10%)

USD 1.37B
SLP Simulations Plus Inc

-0.96 (-2.10%)

USD 0.88B
MPLN MultiPlan Corporation

N/A

USD 0.43B
AMWL American Well Corp

-0.01 (-2.13%)

USD 0.16B
OWLT Owlet Inc

+0.18 (+4.52%)

USD 0.03B

ETFs Containing PHR

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.36% 73% C 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.36% 73% C 56% F
Trailing 12 Months  
Capital Gain -20.76% 55% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -20.76% 55% F 10% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 16.67% 82% B 82% B
Dividend Return 16.67% 82% B 80% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 66.79% 45% F 13% F
Risk Adjusted Return 24.95% 73% C 50% F
Market Capitalization 1.30B 55% F 58% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector